Literature DB >> 28798207

Financial implications of Idylla testing in colorectal cancer, lung cancer and melanoma: a French laboratory point of view.

Glen Le Flahec1, Briac Guibourg1, Pascale Marcorelles1,2, Arnaud Uguen1,2.   

Abstract

Entities:  

Keywords:  colorectal cancer; lung cancer; melanoma

Mesh：

Year:  2017        PMID： 28798207     DOI： 10.1136/jclinpath-2017-204579

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  3 in total

1.  Utility of Select Gene Mutation Detection in Tumors by the Idylla Rapid Multiplex PCR Platform in Comparison to Next-Generation Sequencing.

Authors:  Dingani Nkosi; Vektra L Casler; Chauncey R Syposs; Zoltán N Oltvai
Journal:  Genes (Basel)       Date:  2022-04-29       Impact factor: 4.141

2.  Prospective evaluation of two screening methods for molecular testing of metastatic melanoma: Diagnostic performance of BRAF V600E immunohistochemistry and of a NRAS-BRAF fully automated real-time PCR-based assay.

Authors:  Audrey Vallée; Marie Denis-Musquer; Guillaume Herbreteau; Sandrine Théoleyre; Céline Bossard; Marc G Denis
Journal:  PLoS One       Date:  2019-08-15       Impact factor: 3.240

3.  Contribution of the IdyllaTM System to Improving the Therapeutic Care of Patients with NSCLC through Early Screening of EGFR Mutations.

Authors:  Constance Petiteau; Gwladys Robinet-Zimmermann; Adèle Riot; Marine Dorbeau; Nicolas Richard; Cécile Blanc-Fournier; Frédéric Bibeau; Simon Deshayes; Emmanuel Bergot; Radj Gervais; Guénaëlle Levallet
Journal:  Curr Oncol       Date:  2021-11-03       Impact factor: 3.677
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.